Financhill
Back

Teva Pharmaceutical Industries 10K Form

Buy
57

TEVA
Teva Pharmaceutical Industries

Last Price:
18.78
Seasonality Move:
12.65%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive TEVA News And Ratings

See the #1 stock for the next 7 days that we like better than TEVA

TEVA Financial Statistics

Sales & Book Value

Annual Sales: $15.85B
Cash Flow: $6M
Price / Cash Flow: 30.95
Annual Sales: $5.61
Price / Book: 3.32

Profitability

EPS (TTM): -0.39000
Net Income (TTM): $-476M
Gross Margin: $7.65B
Return on Equity: -6.36%
Return on Assets: -1.12%

Teva Pharmaceutical Industries Earnings Forecast

Key Teva Pharmaceutical Industries Financial Ratios

  • The Gross Profit Margin over the past 38 years for TEVA is 48.25%.
  • The Selling, General & Administrative Expenses for TEVA have been equal to 22.08% of Gross Profit Margin.
  • The Research & Development expenses have been 6.01% of Revenue.
  • The Interest Expense is -184.08% of Operating Income.
  • The Net Earning history of TEVA is -3.53% of Total Revenues.
  • Per Share Earnings over the last 38 years have been positive in 21 years.

Teva Pharmaceutical Industries Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: TEVA
CUSIP: 881624
Website: tevapharm.com

Debt

Debt-to-Equity Ratio: 2.93
Current Ratio: 0.89
Quick Ratio: 0.46

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 6.72

TEVA Technical Analysis vs Fundamental Analysis

Buy
57
Teva Pharmaceutical Industries (TEVA) is a Buy

Is Teva Pharmaceutical Industries a Buy or a Sell?